TREA

79363428 - MANUVEC

Follow

Information

  • Trademark
  • 79363428
  • Serial Number
    79363428
  • Registration Number
    7349629
  • Filing Date
    January 11, 2023
    3 years ago
  • Registration Date
    April 09, 2024
    2 years ago
  • Transaction Date
    January 17, 2025
    a year ago
  • Status Date
    April 09, 2024
    2 years ago
  • Published for Opposition Date
    January 23, 2024
    2 years ago
  • Location Date
    December 20, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    STEEL, ALYSSA
  • Attorney Docket Number
    19250-0464
    Attorney Name
    Douglas T. Johnson
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MANUVEC
Case File Statements
  • GS0051: Viral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparations, prophylaxis products preparations and other pharmaceutical products preparations and other pharmaceutical products preparations for use in nucleic acid-based therapy, gene therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases
  • GS0441: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
  • GS0421: Scientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics
Case File Event Statements
  • 2/28/2023 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/23/2023 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/24/2023 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/18/2023 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/19/2023 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/20/2023 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/1/2023 - 3 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/1/2023 - 3 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/26/2023 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/7/2023 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/7/2023 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/8/2023 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/18/2023 - 2 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/18/2023 - 2 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/18/2023 - 2 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/18/2023 - 2 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/18/2023 - 2 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/3/2024 - 2 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/3/2024 - 2 years ago
    19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/3/2024 - 2 years ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/22/2024 - 2 years ago
    21 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/23/2024 - 2 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/23/2024 - 2 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/9/2024 - 2 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/9/2024 - 2 years ago
    24 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/19/2024 - a year ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/31/2024 - a year ago
    27 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 1/1/2025 - a year ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/17/2025 - a year ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO